CERVERA TABOADA, ALEJANDRA
CIENCIAS BIOMÉDICAS · Nivel 1
Desde 2021 es Subdirectora de Genómica Poblacional en Instituto Nacional de Medicina Genómica
| Nombre | ALEJANDRA CERVERA TABOADA |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | CIENCIAS BIOMÉDICAS |
| Disciplina | BIOINFORMÁTICA |
| Especialidad | GENOMICA |
| CVU | 360049 |
| Institución | |
|---|---|
| Dependencia | SIN INFORMACIÓN |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2027 |
Publicaciones ORCID
- 2026
- CD25+CD27+CD70− alloantigen-specific Tregs: promising stable immunotherapy for transplantation Frontiers in Immunology
- Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing NAR Cancer
- 2025
- Retrotransposon Expression Is Upregulated in Adulthood and Suppressed during Regeneration of the Limb in the Axolotl (Ambystoma mexicanum) Advanced Biology
- 2024
- Proposal of Reference Genes for Tomato Fruit Ripening qRT-PCR Data Normalization Plant And Cell Physiology
- PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures Neoplasia
- Retrotransposon expression is upregulated by aging and suppressed during regeneration of the limb in the axolotl (Ambystoma mexicanum)
- IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia Frontiers in Oncology
- Case report: A familial B-acute lymphoblastic leukemia associated with a new germline pathogenic variant in PAX5. The first report in Mexico Frontiers in Oncology
- 2023
- Machine Learning and COVID-19: Lessons from SARS-CoV-2 Advances in Experimental Medicine and Biology
- 2022
- Genomic Profile in a Non-Seminoma Testicular Germ-Cell Tumor Cohort Reveals a Potential Biomarker of Sensitivity to Platinum-Based Therapy Cancers